BioPharmaLife is read by Presidents, Directors, ‘C' level executives, Business Heads, Research Heads, Analysts, Venture Capitalists and the Academic community covering Biotech, Pharma and Life Science organizations which are engaged in spectrum of services such as Drug Discovery, Diagnostics, Decease Research, Clinical Research, Clinical Trials, Venture Funding and other related service providers in the above domains across USA, EUROPE and ASIA- PACIFIC.

With an average readership figure of 100,000 every month, the magazine is expected to be read by more than 12, 00,000 high profile business leaders, managers and executives around the world in the next 12 months.